Minerva Neurosciences, Inc. (NERV) Operating cash flow 2016–2025
Minerva Neurosciences, Inc. (NERV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$13.5MFY2025 · since FY2016: -$25.7M → -$13.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.5M | +30.9% |
| FY2024 | -$19.6M | -32.2% |
| FY2023 | -$14.8M | +40.0% |
| FY2022 | -$24.6M | -0.2% |
| FY2021 | -$24.6M | +27.3% |
| FY2020 | -$33.8M | +22.1% |
| FY2019 | -$43.4M | -3.6% |
| FY2018 | -$41.9M | -1456.1% |
| FY2017 | $3.1M | +112.0% |
| FY2016 | -$25.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice